Reactions Weekly

, Volume 1688, Issue 1, pp 55–55 | Cite as

Ceritinib/crizotinib

Emergence of resistance, acute liver function lesion and severe diarrhoea: case report
Case report
  • 6 Downloads

Reference

  1. Liu Z, et al. Does ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review. Clinical and Translational Medicine 7: 1, No. 1, 9 Jan 2018. Available from: URL: http://doi.org/10.1186/s40169-017-0178-x - ChinaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations